NCT03724669

Brief Summary

A retrospective surveys and group interviews focusing on the prescription and abuse of benzodiazepines will be carried out in China. Based the results of retrospective surveys and group interviews and guidelines of benzodiazepines and Z-drugs standardized use, a real-world randomized control trial of would be carried to evaluate the effectiveness of the intervention of using electronic content push in reducing the use rate of psychiatric BZDs and Z-drugs and improving clinical efficiency.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
118

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 28, 2018

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 30, 2018

Completed
2 years until next milestone

Study Start

First participant enrolled

November 10, 2020

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2021

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

March 10, 2022

Status Verified

June 1, 2020

Enrollment Period

8 months

First QC Date

October 28, 2018

Last Update Submit

February 22, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • proportion of inappropriate BZDs and Z-drugs prescription

    The BZDs and Z-drugs prescription information of each psychiatrist within the baseline period (3 months before the intervention) and intervention period (0-3 month) will be extracted from the outpatient prescription database in each hospital. The inappropriate prescription is defined as overdose use (\>40mg), long-term use (\>90 days) or over-indications use.

    3 months before and after the intervention

Secondary Outcomes (5)

  • BZDs and Z-drugs related knowledge

    baseline, 3 months, 6 months

  • Attitude towards BZDs and Z-drugs prescription

    baseline, 3 months, 6 months

  • Common adverse effects in prescribing patients

    baseline, 3 months, 6 months

  • Self-efficacy

    baseline, 3 months, 6 months

  • Utility of the electronic intervention

    3 month

Study Arms (2)

waiting list

PLACEBO COMPARATOR
Behavioral: waiting list

Benzodiazepines and Z-drugs knowledge

EXPERIMENTAL
Behavioral: benzodiazepines related knowledge intervention

Interventions

waiting listBEHAVIORAL

After the study ends, they will have access to receive the educational texts and view the online lectures.

waiting list

participants receiving 11 articles pushing and 3 online lectures through the electronic interventions App, once a week, last for 3 months

Benzodiazepines and Z-drugs knowledge

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • at least 3-year working experience as a psychiatrist;
  • provide outpatient services for at least 1 year with the frequency of more than once a week;
  • willingness to receive standardized electronic interventions on BZDs and Z-drugs prescription.

You may not qualify if:

  • will retire within six months;
  • refuse to extract their prescription information from the outpatient database.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai Mental Health Center

Shanghai, China

Location

Related Publications (1)

  • Xu X, Ye Y, Wang X, Xu J, Li C, Wang G, Zhu Y, Jiang H, Zhong N. Effectiveness and utility of an electronic intervention for appropriate benzodiazepine and Z-drugs prescription in psychiatric clinics: protocol for a multicentric, real-world randomised controlled trial in China. BMJ Open. 2022 Apr 5;12(4):e055341. doi: 10.1136/bmjopen-2021-055341.

MeSH Terms

Interventions

Waiting Lists

Intervention Hierarchy (Ancestors)

Appointments and SchedulesOrganization and AdministrationHealth Services Administration

Study Officials

  • Na Zhong, Doctor

    Shanghai Mental Health Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 28, 2018

First Posted

October 30, 2018

Study Start

November 10, 2020

Primary Completion

June 30, 2021

Study Completion

December 31, 2021

Last Updated

March 10, 2022

Record last verified: 2020-06

Data Sharing

IPD Sharing
Will not share

The prescription data will not be shared with the public. However, if the intervention is effective, the educational materials will be released to the public.

Locations